Oct
2026
Fiera Milano, Italy
Visit us
stand 3K85, API
Jiangsu Simcere Pharmaceutical Co., Ltd
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:China
-
On CPHI since:2019
-
Employees:5000+
Company types
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 3K85, API
Products Featured at CPHI Milan 2026
-
Product Enlength
As a cornerstone drug for the treatment of multiple myeloma, Bortezomib is used throughout the induction, consolidation and maintenance therapies for myeloma. In 2020, Bortezomib was recommended as a first-line drug for the full management of multiple myeloma in the Guidelines for Diagnosis and Treatm... -
Product Lenvatinib Mesilate Capsules
This product is suitable for patients with unresectable hepatocellular carcinoma who have not previously received systemic therapy.The pivotal study of lenvatinib mesylate excluded patients with HCC amenable to local therapy, for whom no study data are available. -
Product Sanbexin
Sanbexin is indicated for the improvement of neurological symptoms, activities of daily living and dysfunction caused by acute cerebral infarction. Category 1 innovative drug with solid medical evidence support. It takes only 5 months from launch to NRDL list. It can improve the neurological function o... -
Product XIANNUOXIN
XIANNUOXIN® (Simnotrelvir Tablets/Ritonavir Tablets co-packaged) as the first domestic oral small molecule anti-COVID-19 3CL inhibitor specially approved by the CDE has been included in the key scientific research project of the Joint Prevention and Control Mechanism of the State Council, and is used t... -
Product XINBIQI
By physical action, BIQI® montmorillonite powders can physically cover the surface of the gastrointestinal tract, and adsorb pathogenic factors, so as to quickly solve various diarrhea problems, without the need to enter the blood circulation, therefore being safe and non-toxic. Its prescription and p...